tradingkey.logo
tradingkey.logo
Search

Biomerica Inc

BMRA
Add to Watchlist
1.750USD
-0.020-1.13%
Close 07/02, 13:00ETQuotes delayed by 15 min
5.16MMarket Cap
LossP/E TTM

More Details of Biomerica Inc Company

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Biomerica Inc Info

Ticker SymbolBMRA
Company nameBiomerica Inc
IPO dateMar 17, 1980
CEOIrani (Zackary S)
Number of employees53
Security typeOrdinary Share
Fiscal year-endMar 17
Address17571 Von Karman Avenue
CityIRVINE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92614
Phone19493792875
Websitehttps://biomerica.com/
Ticker SymbolBMRA
IPO dateMar 17, 1980
CEOIrani (Zackary S)

Company Executives of Biomerica Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Gary M. Huff
Mr. Gary M. Huff
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Biomerica Inc?

The top five shareholders of Biomerica Inc are: Mr. Zackary S. Irani

How many institutions hold shares of Biomerica Inc (BMRA)?

As of 2026Q1, 59 institutions hold shares of Biomerica Inc, with a combined market value of approximately 94.38K, accounting for 3.05% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -250592.00.

What is the biggest source of revenue for Biomerica Inc?

In 2026Q1, the Clinical Lab business generated the highest revenue for Biomerica Inc, amounting to 676.00K and accounting for 55.87% of total revenue.